These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 6697501

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Preservation of urine samples for metabolic evaluation of stone-forming patients.
    Ferraz RR, Baxmann AC, Ferreira LG, Nishiura JL, Siliano PR, Gomes SA, Moreira SR, Heilberg IP.
    Urol Res; 2006 Oct; 34(5):329-37. PubMed ID: 16896690
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E, Imperiali P, Badii M, Capiccioni S, Masi MG, Sasdelli M.
    Proc Eur Dial Transplant Assoc; 1983 Oct; 20():445-9. PubMed ID: 6657667
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effectiveness and mode of action of orthophosphates in patients with calcareous renal calculi.
    Thomas WC.
    Trans Am Clin Climatol Assoc; 1972 Oct; 83():113-24. PubMed ID: 5040108
    [No Abstract] [Full Text] [Related]

  • 9. Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers.
    Robertson WG, Peacock M, Nordin BE.
    Clin Sci; 1971 May; 40(5):365-74. PubMed ID: 5556093
    [No Abstract] [Full Text] [Related]

  • 10. A risk of inaccuracy in biochemical analysis of urinary stone-forming salts.
    Koide T, Oka T, Nakano E, Itatani H, Takaha M, Sonoda T.
    J Urol; 1984 Sep; 132(3):486-9. PubMed ID: 6471182
    [Abstract] [Full Text] [Related]

  • 11. [Circadian rhythms of lithogenic and inhibitory substances in the urine].
    Ebisuno S, Morimoto S, Yasukawa S, Yoshida T, Fukatani T, Minakata S, Uehara M, Ohkawa T.
    Hinyokika Kiyo; 1986 May; 32(5):667-71. PubMed ID: 3751794
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
    Negri AL, Spivacow FR, Del Valle EE, Forrester M, Rosende G, Pinduli I.
    Urol Res; 2008 Dec; 36(6):303-7. PubMed ID: 18985334
    [Abstract] [Full Text] [Related]

  • 14. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
    Takasaki E.
    Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654
    [Abstract] [Full Text] [Related]

  • 15. Relationship between the severity of renal stone disease and urine composition.
    Tiselius HG.
    Eur Urol; 1979 Jan; 5(5):323-7. PubMed ID: 446508
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Circadian rhythm of lithogenic substances in the urine.
    Vahlensieck EW, Bach D, Hesse A.
    Urol Res; 1982 Jan; 10(4):195-203. PubMed ID: 7179612
    [Abstract] [Full Text] [Related]

  • 19. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H, Suzuki F, Yamaguchi K, Nishikawa Y, Kotake T.
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.